Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company has a collaboration with ACEA Therapeutics to Support the Expansion of ZTlido program. Scilex Holding Company is headquartered in Palo Alto, California. more
Time Frame | SCLX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -21.56% | -2.27% | -0.57% |
1-Month Return | -31.42% | -3.96% | 1.21% |
3-Month Return | -55.87% | -9.7% | 7.57% |
6-Month Return | -65.94% | -3.37% | 11.45% |
1-Year Return | -55.87% | 3.71% | 28.48% |
3-Year Return | -94.95% | 3.8% | 29.52% |
5-Year Return | -94.85% | 39.78% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 21.03M | 23.56M | 31.32M | 38.03M | 46.74M | [{"date":"2019-12-31","value":45,"profit":true},{"date":"2020-12-31","value":50.4,"profit":true},{"date":"2021-12-31","value":67,"profit":true},{"date":"2022-12-31","value":81.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 5.80M | 2.15M | 3.63M | 10.80M | 15.68M | [{"date":"2019-12-31","value":37,"profit":true},{"date":"2020-12-31","value":13.7,"profit":true},{"date":"2021-12-31","value":23.17,"profit":true},{"date":"2022-12-31","value":68.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 15.23M | 21.41M | 27.68M | 27.24M | 31.06M | [{"date":"2019-12-31","value":49.03,"profit":true},{"date":"2020-12-31","value":68.93,"profit":true},{"date":"2021-12-31","value":89.12,"profit":true},{"date":"2022-12-31","value":87.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 72.41% | 90.88% | 88.40% | 71.61% | 66.45% | [{"date":"2019-12-31","value":79.68,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.27,"profit":true},{"date":"2022-12-31","value":78.8,"profit":true},{"date":"2023-12-31","value":73.12,"profit":true}] |
Operating Expenses | 153.93M | 56.67M | 63.52M | 77.87M | 136.49M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":36.82,"profit":true},{"date":"2021-12-31","value":41.27,"profit":true},{"date":"2022-12-31","value":50.59,"profit":true},{"date":"2023-12-31","value":88.67,"profit":true}] |
Operating Income | (138.69M) | (35.26M) | (35.84M) | (50.63M) | (105.43M) | [{"date":"2019-12-31","value":-13869500000,"profit":false},{"date":"2020-12-31","value":-3525800000,"profit":false},{"date":"2021-12-31","value":-3583800000,"profit":false},{"date":"2022-12-31","value":-5063400000,"profit":false},{"date":"2023-12-31","value":-10543100000,"profit":false}] |
Total Non-Operating Income/Expense | (56.33M) | (25.43M) | (92.34M) | 17.67M | (10.41M) | [{"date":"2019-12-31","value":-318.77,"profit":false},{"date":"2020-12-31","value":-143.92,"profit":false},{"date":"2021-12-31","value":-522.61,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58.92,"profit":false}] |
Pre-Tax Income | (178.59M) | (47.57M) | (88.42M) | (23.36M) | (114.32M) | [{"date":"2019-12-31","value":-17859200000,"profit":false},{"date":"2020-12-31","value":-4757200000,"profit":false},{"date":"2021-12-31","value":-8841900000,"profit":false},{"date":"2022-12-31","value":-2336000000,"profit":false},{"date":"2023-12-31","value":-11431800000,"profit":false}] |
Income Taxes | 2.00K | (53.00K) | 5.00K | 4.00K | 13.00K | [{"date":"2019-12-31","value":15.38,"profit":true},{"date":"2020-12-31","value":-407.69,"profit":false},{"date":"2021-12-31","value":38.46,"profit":true},{"date":"2022-12-31","value":30.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (178.59M) | (47.52M) | (88.42M) | (23.36M) | (114.33M) | [{"date":"2019-12-31","value":-17859400000,"profit":false},{"date":"2020-12-31","value":-4751900000,"profit":false},{"date":"2021-12-31","value":-8842400000,"profit":false},{"date":"2022-12-31","value":-2336400000,"profit":false},{"date":"2023-12-31","value":-11433100000,"profit":false}] |
Income From Continuous Operations | (178.59M) | (47.52M) | (1.01M) | (23.36M) | (110.81M) | [{"date":"2019-12-31","value":-17859400000,"profit":false},{"date":"2020-12-31","value":-4751900000,"profit":false},{"date":"2021-12-31","value":-100549800,"profit":false},{"date":"2022-12-31","value":-2336400000,"profit":false},{"date":"2023-12-31","value":-11081500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (178.59M) | (47.52M) | (88.42M) | (23.36M) | (114.33M) | [{"date":"2019-12-31","value":-17859400000,"profit":false},{"date":"2020-12-31","value":-4751900000,"profit":false},{"date":"2021-12-31","value":-8842400000,"profit":false},{"date":"2022-12-31","value":-2336400000,"profit":false},{"date":"2023-12-31","value":-11433100000,"profit":false}] |
EPS (Diluted) | - | - | 0.15 | (0.07) | (1.29) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-47.62,"profit":false},{"date":"2023-12-31","value":-875.37,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SCLX | |
---|---|
Cash Ratio | 0.03 |
Current Ratio | 0.20 |
Quick Ratio | 0.19 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SCLX | |
---|---|
ROA (LTM) | -53.64% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SCLX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 3.05 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -2.05 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SCLX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.34 |
P/B | 28.85 |
Price/FCF | 31 |
EV/R | 3.31 |
EV/Ebitda | NM |
Scilex Holding Company (SCLX) share price today is $0.5075
Yes, Indians can buy shares of Scilex Holding Company (SCLX) on Vested. To buy Scilex Holding Company from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SCLX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Scilex Holding Company (SCLX) via the Vested app. You can start investing in Scilex Holding Company (SCLX) with a minimum investment of $1.
You can invest in shares of Scilex Holding Company (SCLX) via Vested in three simple steps:
The 52-week high price of Scilex Holding Company (SCLX) is $2.63. The 52-week low price of Scilex Holding Company (SCLX) is $0.46.
The price-to-earnings (P/E) ratio of Scilex Holding Company (SCLX) is
The price-to-book (P/B) ratio of Scilex Holding Company (SCLX) is 28.85
The dividend yield of Scilex Holding Company (SCLX) is 0.00%
The market capitalization of Scilex Holding Company (SCLX) is $79.01M
The stock symbol (or ticker) of Scilex Holding Company is SCLX